Advertisement

Archives of Toxicology

, Volume 91, Issue 4, pp 1545–1563 | Cite as

Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD)

  • Salamah Mohammad Alwahsh
  • Rolf Gebhardt
Review Article

Abstract

Glucose is a major energy source for the entire body, while fructose metabolism occurs mainly in the liver. Fructose consumption has increased over the last decade globally and is suspected to contribute to the increased incidence of non-alcoholic fatty liver disease (NAFLD). NAFLD is a manifestation of metabolic syndrome affecting about one-third of the population worldwide and has progressive pathological potential for liver cirrhosis and cancer through non-alcoholic steatohepatitis (NASH). Here we have reviewed the possible contribution of fructose to the pathophysiology of NAFLD. We critically summarize the current findings about several regulators, and their potential mechanisms, that have been studied in humans and animal models in response to fructose exposure. A novel hypothesis on fructose-dependent perturbation of liver regeneration and metabolism is advanced. Fructose intake could affect inflammatory and metabolic processes, liver function, gut microbiota, and portal endotoxin influx. The role of the brain in controlling fructose ingestion and the subsequent development of NAFLD is highlighted. Although the importance for fructose (over)consumption for NAFLD in humans is still debated and comprehensive intervention studies are invited, understanding of how fructose intake can favor these pathological processes is crucial for the development of appropriate noninvasive diagnostic and therapeutic approaches to detect and treat these metabolic effects. Still, lifestyle modification, to lessen the consumption of fructose-containing products, and physical exercise are major measures against NAFLD. Finally, promising drugs against fructose-induced insulin resistance and hepatic dysfunction that are emerging from studies in rodents are reviewed, but need further validation in human patients.

Keywords

Insulin resistance Inflammation Metabolic syndrome (MetS) Gut microbiota Herbal medicine Biomarkers The brain Ethanol Humans Oxidative stress Liver regeneration ATP 

Abbreviations

CYP2E1

Cytochrome 450 2E1

ER

Endoplasmic reticulum

GLUT

Glucose transporter

HDL

High-density lipoprotein

HFCS

High-fructose corn syrup

HFD

High-fat diet

IR

Insulin resistance

IRS-1/2

Insulin receptor substrate 1/2

LCN2

Lipocalin 2

LDL

High-density lipoprotein

LPS

Lipopolysaccharide

Ltf

Lactoferrin

MC4R

Melanocortin receptor 4

MetS

Metabolic syndrome

NAFLD

Non-alcoholic fatty liver disease

NASH

Non-alcoholic steatohepatitis

PAI-1

Plasminogen activator inhibitor-1

ROS

Reactive oxygen species

T2D

Type 2 diabetes mellitus

TG

Triglycerides

TLR4

Toll-like receptor 4

TNF-α

Tumor necrosis factor-α

Notes

Acknowledgements

S.M.A. and R.G. conceived, designed, wrote, and approved the final manuscript. The authors thank Dr. John Hallett, MCR Centre for Regenerative Medicine, The University of Edinburgh, UK, for proofreading the paper.

Funding

This study was supported by grants from the Bundesministerium für Forschung und Technologie (BMBF) in the framework of the Systems Biology initiative “Virtual Liver Network” to RG (Grant: 0315735).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. Abdelmalek MF, Suzuki A, Guy C et al (2010) Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 51:1961–1971. doi: 10.1002/hep.23535 PubMedPubMedCentralCrossRefGoogle Scholar
  2. Abdelmalek MF, Lazo M, Horska A et al (2012) Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes. Hepatology 56:952–960. doi: 10.1002/hep.25741 PubMedPubMedCentralCrossRefGoogle Scholar
  3. Agrawal R, Noble E, Vergnes L et al (2015) Dietary fructose aggravates the pathobiology of traumatic brain injury by influencing energy homeostasis and plasticity. J Cereb Blood Flow Metab 36:941–953. doi: 10.1177/0271678X15606719 PubMedCrossRefGoogle Scholar
  4. Ahmad S, Sultan S, Naz N et al (2014) Regulation of iron uptake in primary culture rat hepatocytes: the role of acute-phase cytokines. Shock 41:337–345. doi: 10.1097/SHK.0000000000000107 PubMedCrossRefGoogle Scholar
  5. Albuquerque D, Estévez MN, Víbora PB et al (2014) Novel variants in the MC4R and LEPR genes among severely obese children from the iberian population. Ann Hum Genet 78:195–207. doi: 10.1111/ahg.12058 PubMedCrossRefGoogle Scholar
  6. Al-Busafi SA, Bhat M, Wong P et al (2012) Antioxidant therapy in nonalcoholic steatohepatitis. Hepat Res Treat 2012:947575. doi: 10.1155/2012/947575 PubMedPubMedCentralGoogle Scholar
  7. Alwahsh SM, Ramadori G (2015) How does bariatric surgery improve type II diabetes? The neglected importance of the liver in clearing glucose and insulin from the portal blood. J Obes Weight Loss Ther 5:5–8. doi: 10.4172/2165-7904.1000280 CrossRefGoogle Scholar
  8. Alwahsh SM, Xu M, Schultze FC et al (2014a) Combination of alcohol and fructose exacerbates metabolic imbalance in terms of hepatic damage, dyslipidemia, and insulin resistance in rats. PLoS ONE 9:e104220. doi: 10.1371/journal.pone.0104220 PubMedPubMedCentralCrossRefGoogle Scholar
  9. Alwahsh SM, Xu M, Seyhan HA et al (2014b) Diet high in fructose leads to an overexpression of lipocalin-2 in rat fatty liver. World J Gastroenterol 20:1807–1821. doi: 10.3748/wjg.v20.i7.1807 PubMedPubMedCentralCrossRefGoogle Scholar
  10. Aron-Wisnewsky J, Gaborit B, Dutour A, Clement K (2013) Gut microbiota and non-alcoholic fatty liver disease: new insights. Clin Microbiol Infect 19:338–348. doi: 10.1111/1469-0691.12140 PubMedCrossRefGoogle Scholar
  11. Aroor AR, Habibi J, Ford DA et al (2015) Dipeptidyl peptidase-4 inhibition ameliorates Western diet-induced hepatic steatosis and insulin resistance through hepatic lipid remodeling and modulation of hepatic mitochondrial function. Diabetes 64:1988–2001. doi: 10.2337/db14-0804 PubMedPubMedCentralCrossRefGoogle Scholar
  12. Assy N, Nasser G, Kamayse I et al (2008) Soft drink consumption linked with fatty liver in the absence of traditional risk factors. Can J Gastroenterol 22:811–816PubMedPubMedCentralCrossRefGoogle Scholar
  13. Azhar A, El-Bassossy HM (2014) Pentoxifylline alleviates cardiac ischemia and dysfunction following experimental angina in insulin resistance. PLoS ONE 9:e98281. doi: 10.1371/journal.pone.0098281 PubMedPubMedCentralCrossRefGoogle Scholar
  14. Bakoma B, Berké B, Eklu-Gadegbeku K et al (2014) Effect of Bridelia ferruginea Benth (Euphorbiaceae) ethyl acetate and acetone fractions on insulin resistance in fructose drinking mice. J Ethnopharmacol 153:896–899. doi: 10.1016/j.jep.2014.03.065 PubMedCrossRefGoogle Scholar
  15. Barker CE, Ali S, O’Boyle G, Kirby JA (2014) Transplantation and inflammation: implications for the modification of chemokine function. Immunology 143:138–145. doi: 10.1111/imm.12332 PubMedPubMedCentralCrossRefGoogle Scholar
  16. Basaranoglu M, Basaranoglu G, Bugianesi E (2015) Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction. Hepatobiliary Surg Nutr 4:109–116. doi: 10.3978/j.issn.2304-3881.2014.11.05 PubMedPubMedCentralGoogle Scholar
  17. Bellentani S, Scaglioni F, Marino M, Bedogni G (2010) Epidemiology of non-alcoholic fatty liver disease. Dig Dis 28:155–161. doi: 10.1159/000282080 PubMedCrossRefGoogle Scholar
  18. Bergheim I, Weber S, Vos M et al (2008) Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J Hepatol 48:983–992. doi: 10.1016/j.jhep.2008.01.035 PubMedCrossRefGoogle Scholar
  19. Bettaieb A, Vazquez Prieto MA, Rodriguez Lanzi C et al (2014) (−)-Epicatechin mitigates high-fructose-associated insulin resistance by modulating redox signaling and endoplasmic reticulum stress. Free Radic Biol Med 72:247–256. doi: 10.1016/j.freeradbiomed.2014.04.011 PubMedPubMedCentralCrossRefGoogle Scholar
  20. Birkenfeld AL, Shulman GI (2014) Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology 59:713–723. doi: 10.1002/hep.26672 PubMedPubMedCentralCrossRefGoogle Scholar
  21. Boesch C, Elsing C, Wegmüller H et al (1997) Effect of ethanol and fructose on liver metabolism a dynamic 31 phosphorus magnetic resonance spectroscopy study in normal volunteers. Magn Reson Imaging 15:1067–1077PubMedCrossRefGoogle Scholar
  22. Borkham-Kamphorst E, Drews F, Weiskirchen R (2011) Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1β through nuclear factor-κB activation. Liver Int 31:656–665. doi: 10.1111/j.1478-3231.2011.02495.x PubMedCrossRefGoogle Scholar
  23. Bray GA, Popkin BM (2014) Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes? Health be damned! Pour on the sugar. Diabetes Care 37:950–956. doi: 10.2337/dc13-2085 PubMedCrossRefGoogle Scholar
  24. Bray GA, Nielsen SJ, Popkin BM (2004) Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 89:537–543Google Scholar
  25. Brown SS, Forrest JA, Roscoe P (1972) A controlled trial of fructose in the treatment of acute alcoholic intoxication. Lancet 2:898–899PubMedCrossRefGoogle Scholar
  26. Butler AA, St-Onge M-P, Siebert EA et al (2015) Differential responses of plasma adropin concentrations to dietary glucose or fructose consumption in humans. Sci Rep 5:14691. doi: 10.1038/srep14691 PubMedPubMedCentralCrossRefGoogle Scholar
  27. Carvalhana S, Machado MV, Cortez-Pinto H (2012) Improving dietary patterns in patients with nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care 15:468–473. doi: 10.1097/MCO.0b013e3283566614 PubMedCrossRefGoogle Scholar
  28. Cha SH, Wolfgang M, Tokutake Y et al (2008) Differential effects of central fructose and glucose on hypothalamic malonyl-CoA and food intake. Proc Natl Acad Sci USA 105:16871–16875. doi: 10.1073/pnas.0809255105 PubMedPubMedCentralCrossRefGoogle Scholar
  29. Charlton M, Krishnan A, Viker K et al (2011) Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition. Am J Physiol Gastrointest Liver Physiol 301:G825–G834. doi: 10.1152/ajpgi.00145.2011 PubMedPubMedCentralCrossRefGoogle Scholar
  30. Chung M, Ma J, Patel K et al (2014) Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis. Am J Clin Nutr 100:833–849. doi: 10.3945/ajcn.114.086314 PubMedPubMedCentralCrossRefGoogle Scholar
  31. Clayton ZE, Vickers MH, Bernal A et al (2015) Early life exposure to fructose alters maternal, fetal and neonatal hepatic gene expression and leads to sex-dependent changes in lipid metabolism in rat offspring. PLoS ONE 10:e0141962. doi: 10.1371/journal.pone.0141962 PubMedPubMedCentralCrossRefGoogle Scholar
  32. Conlon BA, Beasley JM, Aebersold K et al (2013) Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD). Nutrients 5:4093–4114. doi: 10.3390/nu5104093 PubMedPubMedCentralCrossRefGoogle Scholar
  33. Cortez-Pinto H, Chatham J, Chacko V et al (1999) Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis a pilot study. JAMA 282:1659–1664PubMedCrossRefGoogle Scholar
  34. Cox CL, Stanhope KL, Schwarz JM et al (2012) Consumption of fructose—but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gamma-glutamyl transferase activity in overweight/obese humans. Nutr Metab 9:68. doi: 10.1186/1743-7075-9-68 CrossRefGoogle Scholar
  35. Crescenzo R, Bianco F, Falcone I et al (2013) Increased hepatic de novo lipogenesis and mitochondrial efficiency in a model of obesity induced by diets rich in fructose. Eur J Nutr 52:537–545. doi: 10.1007/s00394-012-0356-y PubMedCrossRefGoogle Scholar
  36. Dam-Larsen S, Franzmann M, Andersen IB et al (2004) Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut 53:750–755PubMedPubMedCentralCrossRefGoogle Scholar
  37. DeBosch BJ, Chen Z, Saben JL et al (2014) Glucose transporter 8 (GLUT8) mediates fructose-induced de Novo lipogenesis and macrosteatosis. J Biol Chem 289:10989–10998. doi: 10.1074/jbc.M113.527002 PubMedPubMedCentralCrossRefGoogle Scholar
  38. Di Luccia B, Crescenzo R, Mazzoli A et al (2015) Rescue of fructose-induced metabolic syndrome by antibiotics or faecal transplantation in a rat model of obesity. PLoS ONE 10:e0134893. doi: 10.1371/journal.pone.0134893 PubMedPubMedCentralCrossRefGoogle Scholar
  39. Downing LE, Heidker RM, Caiozzi GC et al (2015) A grape seed procyanidin extract ameliorates fructose-induced hypertriglyceridemia in rats via enhanced fecal bile acid and cholesterol excretion and inhibition of hepatic lipogenesis. PLoS ONE 10:e0140267. doi: 10.1371/journal.pone.0140267 PubMedPubMedCentralCrossRefGoogle Scholar
  40. Dupas J, Goanvec C, Feray A et al (2016) Progressive induction of type 2 diabetes: effects of a reality-like fructose enriched diet in young wistar rats. PLoS ONE 11:e0146821. doi: 10.1371/journal.pone.0146821 PubMedPubMedCentralCrossRefGoogle Scholar
  41. Edmison J, McCullough AJ (2007) Pathogenesis of non-alcoholic steatohepatitis: human data. Clin Liver Dis 11:75–104. doi: 10.1016/j.cld.2007.02.011 PubMedCrossRefGoogle Scholar
  42. Ekstedt M, Franzén LE, Mathiesen UL et al (2006) Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 44:865–873. doi: 10.1002/hep.21327 PubMedCrossRefGoogle Scholar
  43. Engstler AJ, Aumiller T, Degen C et al (2015) Insulin resistance alters hepatic ethanol metabolism: studies in mice and children with non-alcoholic fatty liver disease. Gut 65:1564–1571. doi: 10.1136/gutjnl-2014-308379 PubMedCrossRefGoogle Scholar
  44. Erlanson-Albertsson C, Lindqvist A (2010) Fructose affects enzymes involved in the synthesis and degradation of hypothalamic endocannabinoids. Regul Pept 161:87–91. doi: 10.1016/j.regpep.2010.01.003 PubMedCrossRefGoogle Scholar
  45. Feige JN, Lagouge M, Canto C et al (2008) Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab 8:347–358. doi: 10.1016/j.cmet.2008.08.017 PubMedCrossRefGoogle Scholar
  46. Fernández-Novell JM, Ramió-Lluch L, Orozco A et al (2014) Glucose and fructose have sugar-specific effects in both liver and skeletal muscle in vivo: a role for liver fructokinase. PLoS ONE 9:e109726. doi: 10.1371/journal.pone.0109726 PubMedPubMedCentralCrossRefGoogle Scholar
  47. Frank DN, St Amand AL, Feldman RA et al (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 104:13780–13785. doi: 10.1073/pnas.0706625104 PubMedPubMedCentralCrossRefGoogle Scholar
  48. Gebhardt R, Matz-Soja M (2014) Liver zonation: novel aspects of its regulation and its impact on homeostasis. World J Gastroenterol 20:8491–8504. doi: 10.3748/wjg.v20.i26.8491 PubMedPubMedCentralCrossRefGoogle Scholar
  49. Giriş M, Doğru-Abbasoğlu S, Kumral A et al (2014) Effect of carnosine alone or combined with α-tocopherol on hepatic steatosis and oxidative stress in fructose-induced insulin-resistant rats. J Physiol Biochem 70:385–395. doi: 10.1007/s13105-014-0314-7 PubMedCrossRefGoogle Scholar
  50. Gorden DL, Ivanova PT, Myers DS et al (2011) Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model. PLoS ONE 6:e22775. doi: 10.1371/journal.pone.0022775 PubMedPubMedCentralCrossRefGoogle Scholar
  51. Guimaraes PS, Oliveira MF, Braga JF et al (2014) Increasing angiotensin-(1–7) levels in the brain attenuates metabolic syndrome-related risks in fructose-fed rats. Hypertension 63:1078–1085. doi: 10.1161/HYPERTENSIONAHA.113.01847 PubMedCrossRefGoogle Scholar
  52. Guo H, Jin D, Zhang Y et al (2010) Lipocalin-2 deficiency impairs thermogenesis and potentiates diet-induced insulin resistance in mice. Diabetes 59:1376–1385. doi: 10.2337/db09-1735 PubMedPubMedCentralCrossRefGoogle Scholar
  53. Hirahatake KM, Meissen JK, Fiehn O, Adams SH (2011) Comparative effects of fructose and glucose on lipogenic gene expression and intermediary metabolism in HepG2 liver cells. PLoS ONE 6:e26583. doi: 10.1371/journal.pone.0026583 PubMedPubMedCentralCrossRefGoogle Scholar
  54. Ishimoto T, Lanaspa MA, Rivard CJ et al (2013) High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase. Hepatology 58:1632–1643. doi: 10.1002/hep.26594 PubMedPubMedCentralCrossRefGoogle Scholar
  55. Johnson RJ, Nakagawa T, Sanchez-Lozada LG et al (2013) Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes 62:3307–3315. doi: 10.2337/db12-1814 PubMedPubMedCentralCrossRefGoogle Scholar
  56. Johnston RD, Stephenson MC, Crossland H et al (2013) No difference between high-fructose and high-glucose diets on liver triacylglycerol or biochemistry in healthy overweight men. Gastroenterology 145:1016–1025.e2. doi: 10.1053/j.gastro.2013.07.012 PubMedCrossRefGoogle Scholar
  57. Kanuri G, Spruss A, Wagnerberger S et al (2011a) Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice. J Nutr Biochem 22:527–534. doi: 10.1016/j.jnutbio.2010.04.007 PubMedCrossRefGoogle Scholar
  58. Kanuri G, Spruss A, Wagnerberger S et al (2011b) Fructose-induced steatosis in mice: role of plasminogen activator inhibitor-1, microsomal triglyceride transfer protein and NKT cells. Lab Invest 91:885–895. doi: 10.1038/labinvest.2011.44 PubMedCrossRefGoogle Scholar
  59. Kavanagh K, Wylie AT, Tucker KL et al (2013) Dietary fructose induces endotoxemia and hepatic injury in calorically controlled primates. Am J Clin Nutr 98:349–357. doi: 10.3945/ajcn.112.057331 PubMedPubMedCentralCrossRefGoogle Scholar
  60. Kawasaki T, Igarashi K, Koeda T et al (2009) Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic steatosis. J Nutr 139:2067–2071. doi: 10.3945/jn.109.105858 PubMedCrossRefGoogle Scholar
  61. Kelishadi R, Mansourian M, Heidari-Beni M (2014) Association of fructose consumption and components of metabolic syndrome in human studies: a systematic review and meta-analysis. Nutrition 30:503–510. doi: 10.1016/j.nut.2013.08.014 PubMedCrossRefGoogle Scholar
  62. Koliaki C (2013) Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease. Mol Cell Endocrinol 379:35–42. doi: 10.1016/j.mce.2013.06.002 PubMedCrossRefGoogle Scholar
  63. Korieh A, Crouzoulon G (1991) Dietary regulation of fructose metabolism in the intestine and in the liver of the rat. Duration of the effects of a high fructose diet after the return to the standard diet. Arch Int Physiol Biochim Biophys 99:455–460PubMedGoogle Scholar
  64. Lanaspa MA, Cicerchi C, Garcia G et al (2012a) Counteracting roles of AMP deaminase and AMP kinase in the development of fatty liver. PLoS ONE 7:e48801. doi: 10.1371/journal.pone.0048801 PubMedPubMedCentralCrossRefGoogle Scholar
  65. Lanaspa MA, Sanchez-Lozada LG, Choi YJ et al (2012b) Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: Potential role in fructose-dependent and -independent fatty liver. J Biol Chem 287:40732–40744. doi: 10.1074/jbc.M112.399899 PubMedPubMedCentralCrossRefGoogle Scholar
  66. Lanaspa MA, Ishimoto T, Li N et al (2013) Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome. Nat Commun 4:2434. doi: 10.1038/ncomms3434 PubMedPubMedCentralGoogle Scholar
  67. Latta M, Künstle G, Lucas R et al (2007) ATP-depleting carbohydrates prevent tumor necrosis factor receptor 1-dependent apoptotic and necrotic liver injury in mice. J Pharmacol Exp Ther 321:875–883. doi: 10.1124/jpet.107.119958 PubMedCrossRefGoogle Scholar
  68. Lettner A, Roden M (2008) Ectopic fat and insulin resistance. Curr Diab Rep 8:185–191PubMedCrossRefGoogle Scholar
  69. Li YC, Hsieh CC (2014) Lactoferrin dampens high-fructose corn syrup-induced hepatic manifestations of the metabolic syndrome in a murine model. PLoS ONE 9:e97341. doi: 10.1371/journal.pone.0097341 PubMedPubMedCentralCrossRefGoogle Scholar
  70. Li M, Reynolds CM, Sloboda DM et al (2013) Effects of taurine supplementation on hepatic markers of inflammation and lipid metabolism in mothers and offspring in the setting of maternal obesity. PLoS ONE 8:e76961. doi: 10.1371/journal.pone.0076961 PubMedPubMedCentralCrossRefGoogle Scholar
  71. Li J-M, Ge C-X, Xu M-X et al (2015) Betaine recovers hypothalamic neural injury by inhibiting astrogliosis and inflammation in fructose-fed rats. Mol Nutr Food Res 59:189–202. doi: 10.1002/mnfr.201400307 PubMedCrossRefGoogle Scholar
  72. Lim JS, Mietus-Snyder M, Valente A et al (2010) The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol 7:251–264. doi: 10.1038/nrgastro.2010.41 PubMedCrossRefGoogle Scholar
  73. Lin HZ, Yang SQ, Chuckaree C et al (2000) Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nat Med 6:998–1003. doi: 10.1038/79697 PubMedCrossRefGoogle Scholar
  74. Lindqvist A, Baelemans A, Erlanson-Albertsson C (2008) Effects of sucrose, glucose and fructose on peripheral and central appetite signals. Regul Pept 150:26–32. doi: 10.1016/j.regpep.2008.06.008 PubMedCrossRefGoogle Scholar
  75. Liu J, Zhang H, Ji B et al (2014a) A diet formula of Puerariae radix, Lycium barbarum, Crataegus pinnatifida, and Polygonati rhizoma alleviates insulin resistance and hepatic steatosis in CD-1 mice and HepG2 cells. Food Funct 5:1038–1049. doi: 10.1039/c3fo60524h PubMedCrossRefGoogle Scholar
  76. Liu X, Xue R, Ji L et al (2014b) Activation of farnesoid X receptor (FXR) protects against fructose-induced liver steatosis via inflammatory inhibition and ADRP reduction. Biochem Biophys Res Commun 450:117–123. doi: 10.1016/j.bbrc.2014.05.072 PubMedCrossRefGoogle Scholar
  77. Lou P-H, Yang G, Huang L et al (2010) Reduced body weight and increased energy expenditure in transgenic mice over-expressing soluble leptin receptor. PLoS ONE 5:e11669. doi: 10.1371/journal.pone.0011669 PubMedPubMedCentralCrossRefGoogle Scholar
  78. Lustig RH (2010) Fructose: metabolic, hedonic, and societal parallels with ethanol. J Am Diet Assoc 110:1307–1321. doi: 10.1016/j.jada.2010.06.008 PubMedCrossRefGoogle Scholar
  79. Mahli A, Thasler WE, Patsenker E et al (2015) Identification of cytochrome CYP2E1 as critical mediator of synergistic effects of alcohol and cellular lipid accumulation in hepatocytes in vitro. Oncotarget 6:41464–41478. doi: 10.18632/oncotarget.6203 PubMedPubMedCentralGoogle Scholar
  80. Makki K, Taront S, Molendi-Coste O et al (2014) Beneficial metabolic effects of rapamycin are associated with enhanced regulatory cells in diet-induced obese mice. PLoS ONE 9:e92684. doi: 10.1371/journal.pone.0092684 PubMedPubMedCentralCrossRefGoogle Scholar
  81. Malkusz DC, Yenko I, Rotella FM et al (2015) Dopamine receptor signaling in the medial orbital frontal cortex and the acquisition and expression of fructose-conditioned flavor preferences in rats. Brain Res 1596:116–125. doi: 10.1016/j.brainres.2014.11.028 PubMedCrossRefGoogle Scholar
  82. Marriott BP, Cole N, Lee E (2009) National estimates of dietary fructose intake increased from 1977 to 2004 in the United States. J Nutr 139:1228S–1235S. doi: 10.3945/jn.108.098277 PubMedCrossRefGoogle Scholar
  83. Martius G, Alwahsh SM, Rave-Fränk M et al (2014) Hepatic fat accumulation and regulation of FAT/CD36: an effect of hepatic irradiation. Int J Clin Exp Pathol 7:5379–5392PubMedPubMedCentralGoogle Scholar
  84. Mate A, De La Hermosa MA, Barfull A et al (2001) Characterization of d-fructose transport by rat kidney brush-border membrane vesicles: changes in hypertensive rats. Cell Mol Life Sci 58:1961–1967PubMedCrossRefGoogle Scholar
  85. Matz-Soja M, Rennert C, Schönefeld K et al (2016) Hedgehog signaling is a potent regulator of liver lipid metabolism and reveals a GLI-code associated with steatosis. eLife 5:e13308. doi: 10.7554/eLife.13308.001 PubMedPubMedCentralCrossRefGoogle Scholar
  86. Michael MD, Kulkarni RN, Postic C et al (2000) Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6:87–97PubMedCrossRefGoogle Scholar
  87. Montonen J, Järvinen R, Knekt P et al (2007) Consumption of sweetened beverages and intakes of fructose and glucose predict type 2 diabetes occurrence. J Nutr 137:1447–1454PubMedGoogle Scholar
  88. Morishita S, Ono T, Fujisaki C et al (2013) Bovine lactoferrin reduces visceral fat and liver triglycerides in ICR mice. J Oleo Sci 62:97–103PubMedCrossRefGoogle Scholar
  89. Mortensen OH, Larsen LH, Ørstrup LKH et al (2014) Developmental programming by high fructose decreases phosphorylation efficiency in aging offspring brain mitochondria, correlating with enhanced UCP5 expression. J Cereb Blood Flow Metab 34:1205–1211. doi: 10.1038/jcbfm.2014.72 PubMedPubMedCentralCrossRefGoogle Scholar
  90. Mouzaki M, Comelli EM, Arendt BM et al (2013) Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology 58:120–127. doi: 10.1002/hep.26319 PubMedCrossRefGoogle Scholar
  91. Mukai Y, Ozaki H, Serita Y, Sato S (2014) Maternal fructose intake during pregnancy modulates hepatic and hypothalamic AMP-activated protein kinase signalling in a sex-specific manner in offspring. Clin Exp Pharmacol Physiol 41:331–337. doi: 10.1111/1440-1681.12225 PubMedCrossRefGoogle Scholar
  92. Nair S, Chacko VP, Arnold C, Diehl AM (2003) Hepatic ATP reserve and efficiency of replenishing: comparison between obese and nonobese normal individuals. Am J Gastroenterol 98:466–470. doi: 10.1016/S0002-9270(02)05889-6 PubMedGoogle Scholar
  93. Nair S, Diehl AM, Wiseman M et al (2004) Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial. Aliment Pharmacol Ther 20:23–28. doi: 10.1111/j.1365-2036.2004.02025.x PubMedCrossRefGoogle Scholar
  94. Nakagawa T, Hu H, Zharikov S et al (2006) A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 290:F625–F631. doi: 10.1152/ajprenal.00140.2005 PubMedCrossRefGoogle Scholar
  95. Nan Y, Wang R, Fu N (2014) Peroxisome proliferator-activated receptor α, a potential therapeutic target for alcoholic liver disease. World J Gastroenterol 20:8055–8060. doi: 10.3748/wjg.v20.i25.8055 PubMedPubMedCentralCrossRefGoogle Scholar
  96. Narasimhan A, Chinnaiyan M, Karundevi B (2015) Ferulic acid regulates hepatic GLUT2 gene expression in high fat and fructose-induced type-2 diabetic adult male rat. Eur J Pharmacol 761:391–397. doi: 10.1016/j.ejphar.2015.04.043 PubMedCrossRefGoogle Scholar
  97. Niklas J, Bonin A, Mangin S et al (2012) Central energy metabolism remains robust in acute steatotic hepatocytes challenged by a high free fatty acid load. BMB Rep 45:396–401PubMedCrossRefGoogle Scholar
  98. Okada E, Oida K, Tada H et al (1999) Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patients with type 2 diabetes. Diabetes Care 22:484–490. doi: 10.2337/diacare.22.3.484 PubMedCrossRefGoogle Scholar
  99. Onyesom I (2005) Honey-induced stimulation of blood ethanol elimination and its influence on serum triacylglycerol and blood pressure in man. Ann Nutr Metab 49:319–324. doi: 10.1159/000087336 PubMedCrossRefGoogle Scholar
  100. Oron-Herman M, Rosenthal T, Sela B-A (2003) Hyperhomocysteinemia as a component of syndrome X. Metabolism 52:1491–1495PubMedCrossRefGoogle Scholar
  101. Ouyang X, Cirillo P, Sautin Y et al (2008) Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 48:993–999. doi: 10.1016/j.jhep.2008.02.011 PubMedPubMedCentralCrossRefGoogle Scholar
  102. Page KA, Chan O, Arora J et al (2013) Effects of fructose vs glucose on regional cerebral blood flow in brain regions involved with appetite and reward pathways. JAMA 309:63. doi: 10.1001/jama.2012.116975 PubMedPubMedCentralCrossRefGoogle Scholar
  103. Pastoret A, Marcos R, Sampayo-Reyes A et al (2013) Inhibition of hepatocyte nuclear factor 1 and 4 alpha (HNF1α and HNF4α) as a mechanism of arsenic carcinogenesis. Arch Toxicol 87:1001–1012. doi: 10.1007/s00204-012-0948-6 PubMedCrossRefGoogle Scholar
  104. Pessayre D, Fromenty B (2005) NASH: a mitochondrial disease. J Hepatol 42:928–940. doi: 10.1016/j.jhep.2005.03.004 PubMedCrossRefGoogle Scholar
  105. Petrie JL, Patman GL, Sinha I et al (2013) The rate of production of uric acid by hepatocytes is a sensitive index of compromised cell ATP homeostasis. Am J Physiol Endocrinol Metab 305:E1255–E1265. doi: 10.1152/ajpendo.00214.2013 PubMedCrossRefGoogle Scholar
  106. Petta S, Marchesini G, Caracausi L et al (2013) Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients. J Hepatol 59:1169–1176. doi: 10.1016/j.jhep.2013.07.037 PubMedCrossRefGoogle Scholar
  107. Prakash P, Singh V, Jain M et al (2014) Silymarin ameliorates fructose induced insulin resistance syndrome by reducing de novo hepatic lipogenesis in the rat. Eur J Pharmacol 727:15–28. doi: 10.1016/j.ejphar.2014.01.038 PubMedCrossRefGoogle Scholar
  108. Pyo Y-H, Lee K-W (2014) Preventive effect of Monascus-fermented products enriched with ubiquinones on type 2 diabetic rats induced by a high-fructose plus high-fat diet. J Med Food 17:826–829. doi: 10.1089/jmf.2013.3001 PubMedPubMedCentralCrossRefGoogle Scholar
  109. Qu H, Li J, Chen W et al (2014) Differential expression of the melanocortin-4 receptor in male and female C57BL/6J mice. Mol Biol Rep 41:3245–3256. doi: 10.1007/s11033-014-3187-5 PubMedCrossRefGoogle Scholar
  110. Raatz SK, Johnson LK, Picklo MJ (2015) Consumption of honey, sucrose, and high-fructose corn syrup produces similar metabolic effects in glucose-tolerant and -intolerant individuals. J Nutr 145:2265–2272. doi: 10.3945/jn.115.218016.1 PubMedCrossRefGoogle Scholar
  111. Rashid A, Wu T-C, Huang C et al (1999) Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology 29:1131–1138PubMedCrossRefGoogle Scholar
  112. Rebollo A, Roglans N, Baena M et al (2014) Liquid fructose downregulates Sirt1 expression and activity and impairs the oxidation of fatty acids in rat and human liver cells. Biochim Biophys Acta Mol Cell Biol Lipids 1841:514–524. doi: 10.1016/j.bbalip.2014.01.002 CrossRefGoogle Scholar
  113. Ren L-P, Chan SMH, Zeng X-Y et al (2012) Differing endoplasmic reticulum stress response to excess lipogenesis versus lipid oversupply in relation to hepatic steatosis and insulin resistance. PLoS ONE 7:e30816. doi: 10.1371/journal.pone.0030816 PubMedPubMedCentralCrossRefGoogle Scholar
  114. Ren D, Zhao Y, Nie Y et al (2014) Chemical composition of Pleurotus eryngii polysaccharides and their inhibitory effects on high-fructose diet-induced insulin resistance and oxidative stress in mice. Food Funct 5:2609–2620. doi: 10.1039/c3fo60640f PubMedCrossRefGoogle Scholar
  115. Renaud HJ, Cui JY, Lu H, Klaassen CD (2014) Effect of diet on expression of genes involved in lipid metabolism, oxidative stress, and inflammation in mouse liver-insights into mechanisms of hepatic steatosis. PLoS ONE 9:e88584. doi: 10.1371/journal.pone.0088584 PubMedPubMedCentralCrossRefGoogle Scholar
  116. Riby JE, Fujisawa T, Kretchmer N (1993) Fructose absorption. Am J Clin Nutr 58:748S–753SPubMedGoogle Scholar
  117. Ritze Y, Bárdos G, D’Haese JG et al (2014) Effect of high sugar intake on glucose transporter and weight regulating hormones in mice and humans. PLoS ONE 9:e101702. doi: 10.1371/journal.pone.0101702 PubMedPubMedCentralCrossRefGoogle Scholar
  118. Rivera FP, Medina AM, Bezada S et al (2013) Bovine lactoferrin decreases cholera-toxin-induced intestinal fluid accumulation in mice by ganglioside interaction. PLoS ONE 8:e59253. doi: 10.1371/journal.pone.0059253 PubMedPubMedCentralCrossRefGoogle Scholar
  119. Rodrigues DF, do Carmo Henriques MC, Oliveira MC et al (2014) Acute intake of a high-fructose diet alters the balance of adipokine concentrations and induces neutrophil influx in the liver. J Nutr Biochem 25:388–394. doi: 10.1016/j.jnutbio.2013.11.012 PubMedCrossRefGoogle Scholar
  120. Rokutan M, Yabe D, Komoto I et al (2015) A case of insulinoma with non-alcoholic fatty liver disease: roles of hyperphagia and hyperinsulinemia in pathogenesis of the disease. Endocr J 62:1025–1030. doi: 10.1507/endocrj.EJ14-0590 PubMedCrossRefGoogle Scholar
  121. Rorabaugh JM, Stratford JM, Zahniser NR (2014) A relationship between reduced nucleus accumbens shell and enhanced lateral hypothalamic orexin neuronal activation in long-term fructose bingeing behavior. PLoS ONE 9:e95019. doi: 10.1371/journal.pone.0095019 PubMedPubMedCentralCrossRefGoogle Scholar
  122. Rovenko BM, Perkhulyn NV, Gospodaryov DV et al (2015) High consumption of fructose rather than glucose promotes a diet-induced obese phenotype in Drosophila melanogaster. Comp Biochem Physiol Part A Mol Integr Physiol 180:75–85. doi: 10.1016/j.cbpa.2014.11.008 CrossRefGoogle Scholar
  123. Sakar Y, Nazaret C, Lettéron P et al (2009) Positive regulatory control loop between gut leptin and intestinal GLUT2/GLUT5 transporters links to hepatic metabolic functions in rodents. PLoS ONE 4:e7935. doi: 10.1371/journal.pone.0007935 PubMedPubMedCentralCrossRefGoogle Scholar
  124. Samuel VT, Liu Z-X, Qu X et al (2004) Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 279:32345–32353. doi: 10.1074/jbc.M313478200 PubMedCrossRefGoogle Scholar
  125. Sapp V, Gaffney L, EauClaire SF, Matthews RP (2014) Fructose leads to hepatic steatosis in zebrafish that is reversed by mTOR inhibition. Hepatology 60:1581–1592. doi: 10.1002/hep.27284 PubMedCrossRefGoogle Scholar
  126. Saravanan M, Pandikumar P, Saravanan S et al (2014) Lipolytic and antiadipogenic effects of (3,3-dimethylallyl) halfordinol on 3T3-L1 adipocytes and high fat and fructose diet induced obese C57/BL6J mice. Eur J Pharmacol 740:714–721. doi: 10.1016/j.ejphar.2014.06.004 PubMedCrossRefGoogle Scholar
  127. Scholz R, Nohl H (1976) Mechanism of the stimulatory effect of fructose on ethanol oxidation in perfused rat liver. Eur J Biochem 63:449–458PubMedCrossRefGoogle Scholar
  128. Schwarz J-M, Noworolski SM, Wen MJ et al (2015) Effect of a high-fructose weight-maintaining diet on lipogenesis and liver fat. J Clin Endocrinol Metab 100:2434–2442. doi: 10.1210/jc.2014-3678 PubMedPubMedCentralCrossRefGoogle Scholar
  129. Sclafani A, Ackroff K (1994) Glucose- and fructose-conditioned flavor preferences in rats: taste versus postingestive conditioning. Physiol Behav 56:399–405PubMedCrossRefGoogle Scholar
  130. Sharma S, Mells JE, Fu PP et al (2011) GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy. PLoS ONE 6:e25269. doi: 10.1371/journal.pone.0025269 PubMedPubMedCentralCrossRefGoogle Scholar
  131. Shawky NM, Shehatou GSG, Abdel Rahim M et al (2014) Levocetirizine ameliorates high fructose diet-induced insulin resistance, vascular dysfunction and hepatic steatosis in rats. Eur J Pharmacol 740:353–363. doi: 10.1016/j.ejphar.2014.07.021 PubMedCrossRefGoogle Scholar
  132. Shi P, Chen B, Chen C et al (2015) Honey reduces blood alcohol concentration but not affects the level of serum MDA and GSH-Px activity in intoxicated male mice models. BMC Complement Altern Med 15:225. doi: 10.1186/s12906-015-0766-5 PubMedPubMedCentralCrossRefGoogle Scholar
  133. Shulga N, Pastorino JG (2014) Mitoneet mediates TNFα-induced necroptosis promoted by exposure to fructose and ethanol. J Cell Sci 127:896–907. doi: 10.1242/jcs.140764 PubMedPubMedCentralCrossRefGoogle Scholar
  134. Sloboda DM, Li M, Patel R et al (2014) Early life exposure to fructose and offspring phenotype: implications for long term metabolic homeostasis. J Obes 2014:1–10. doi: 10.1155/2014/203474 CrossRefGoogle Scholar
  135. Soleimani M (2011) Dietary fructose, salt absorption and hypertension in metabolic syndrome: towards a new paradigm. Acta Physiol 201:55–62. doi: 10.1111/j.1748-1716.2010.02167.x CrossRefGoogle Scholar
  136. Song M, Schuschke DA, Zhou Z et al (2012) High fructose feeding induces copper deficiency in Sprague-Dawley rats: a novel mechanism for obesity related fatty liver. J Hepatol 56:433–440. doi: 10.1016/j.surg.2006.10.010.Use PubMedCrossRefGoogle Scholar
  137. Song M, Chen T, Prough RA et al (2016) Chronic alcohol consumption causes liver injury in high-fructose-fed male mice through enhanced hepatic inflammatory response. Alcohol Clin Exp Res 40:518–528. doi: 10.1111/acer.12994 PubMedCrossRefGoogle Scholar
  138. Speicher T, Köhler UA, Choukèr A et al (2012) Fructose protects murine hepatocytes from tumor necrosis factor-induced apoptosis by modulating JNK signaling. J Biol Chem 287:1837–1846. doi: 10.1074/jbc.M111.266742 PubMedCrossRefGoogle Scholar
  139. Spruss A, Kanuri G, Wagnerberger S et al (2009) Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology 50:1094–1104. doi: 10.1002/hep.23122 PubMedCrossRefGoogle Scholar
  140. Spruss A, Kanuri G, Uebel K et al (2011) Role of the inducible nitric oxide synthase in the onset of fructose-induced steatosis in mice. Antioxid Redox Signal 14:2121–2135. doi: 10.1089/ars.2010.3263 PubMedCrossRefGoogle Scholar
  141. Spruss A, Henkel J, Kanuri G et al (2012a) Female mice are more susceptible to nonalcoholic fatty liver disease: sex-specific regulation of the hepatic AMP-activated protein kinase-plasminogen activator inhibitor 1 cascade, but not the hepatic endotoxin response. Mol Med 18:1346–1355. doi: 10.2119/molmed.2012.00223 PubMedPubMedCentralCrossRefGoogle Scholar
  142. Spruss A, Kanuri G, Stahl C et al (2012b) Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function. Lab Investig 92:1020–1032. doi: 10.1038/labinvest.2012.75 PubMedCrossRefGoogle Scholar
  143. Stanhope KL, Schwarz JM, Keim NL et al (2009) Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 119:1322–1334. doi: 10.1172/JCI37385 PubMedPubMedCentralCrossRefGoogle Scholar
  144. Suwannaphet W, Meeprom A, Yibchok-Anun S, Adisakwattana S (2010) Preventive effect of grape seed extract against high-fructose diet-induced insulin resistance and oxidative stress in rats. Food Chem Toxicol 48:1853–1857. doi: 10.1016/j.fct.2010.04.021 PubMedCrossRefGoogle Scholar
  145. Tappy L, Egli L, Lecoultre V, Schneider P (2013) Effects of fructose-containing caloric sweeteners on resting energy expenditure and energy efficiency: a review of human trials. Nutr Metab 10:54. doi: 10.1186/1743-7075-10-54 CrossRefGoogle Scholar
  146. Thuy S, Ladurner R, Volynets V et al (2008) Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr 138:1452–1455PubMedGoogle Scholar
  147. Tilg H, Moschen AR, Roden M (2016) NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol. doi: 10.1038/nrgastro.2016.147 PubMedGoogle Scholar
  148. Tiniakos DG, Vos MB, Brunt EM (2010) Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol 5:145–171. doi: 10.1146/annurev-pathol-121808-102132 PubMedCrossRefGoogle Scholar
  149. Tomita K, Tamiya G, Ando S et al (2006) Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice. Gut 55:415–424. doi: 10.1136/gut.2005.071118 PubMedPubMedCentralCrossRefGoogle Scholar
  150. Uzuegbu UE, Onyesom I (2009) Fructose-induced increase in ethanol metabolism and the risk of Syndrome X in man. C R Biol 332:534–538. doi: 10.1016/j.crvi.2009.01.007 PubMedCrossRefGoogle Scholar
  151. Vilà L, Rebollo A, Ađalsteisson GS et al (2011) Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment. Toxicol Appl Pharmacol 251:32–40. doi: 10.1016/j.taap.2010.11.011 PubMedCrossRefGoogle Scholar
  152. Volynets V, Spruss A, Kanuri G et al (2010) Protective effect of bile acids on the onset of fructose-induced hepatic steatosis in mice. J Lipid Res 51:3414–3424. doi: 10.1194/jlr.M007179 PubMedPubMedCentralCrossRefGoogle Scholar
  153. Volynets V, Machann J, Küper MA et al (2013) A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study. Eur J Nutr 52:527–535. doi: 10.1007/s00394-012-0355-z PubMedCrossRefGoogle Scholar
  154. Vos MB, Kimmons JE, Gillespie C et al (2008) Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey. Medscape J Med 10:160PubMedPubMedCentralGoogle Scholar
  155. Weiland T, Klein K, Zimmermann M et al (2012) Selective protection of human liver tissue in TNF-targeting of cancers of the liver by transient depletion of adenosine triphosphate. PLoS ONE 7:e52496. doi: 10.1371/journal.pone.0052496 PubMedPubMedCentralCrossRefGoogle Scholar
  156. Welsh JA, Sharma AJ, Grellinger L, Vos MB (2011) Consumption of added sugars is decreasing in the United States. Am J Clin Nutr 94:726–734. doi: 10.3945/ajcn.111.018366 PubMedPubMedCentralCrossRefGoogle Scholar
  157. White JS (2008) Straight talk about high-fructose corn syrup: what it is and what it. Am J Clin Nutr 88:1716S–1721S. doi: 10.3945/ajcn.2008.25825B.2 PubMedCrossRefGoogle Scholar
  158. Wigg AJ, Roberts-Thomson IC, Dymock RB et al (2001) The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 48:206–211PubMedPubMedCentralCrossRefGoogle Scholar
  159. Xu M, Alwahsh SM, Ramadori G et al (2013) Upregulation of hepatic melanocortin 4 receptor during rat liver regeneration. J Surg Res. doi: 10.1016/j.jss.2013.12.019 Google Scholar
  160. Xu T, Zheng L, Xu L et al (2014) Protective effects of dioscin against alcohol-induced liver injury. Arch Toxicol. doi: 10.1007/s00204-013-1148-8 Google Scholar
  161. Xu M-X, Yu R, Shao L-F et al (2016) Up-regulated fractalkine (FKN) and its receptor CX3CR1 are involved in fructose-induced neuroinflammation: suppression by curcumin. Brain Behav Immun 58:69–81. doi: 10.1016/j.bbi.2016.01.001 PubMedCrossRefGoogle Scholar
  162. Yin Q, Ma Y, Hong Y et al (2014) Lycopene attenuates insulin signaling deficits, oxidative stress, neuroinflammation, and cognitive impairment in fructose-drinking insulin resistant rats. Neuropharmacology 86:389–396. doi: 10.1016/j.neuropharm.2014.07.020 PubMedCrossRefGoogle Scholar
  163. Yki-Järvinen H (2010) Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data. Curr Opin Clin Nutr Metab Care 13:709–714. doi: 10.1097/MCO.0b013e32833f4b34 PubMedCrossRefGoogle Scholar
  164. Zhao Y, Yang X, Ren D et al (2014) Preventive effects of jujube polysaccharides on fructose-induced insulin resistance and dyslipidemia in mice. Food Funct 5:1771. doi: 10.1039/C3FO60707K PubMedCrossRefGoogle Scholar
  165. Zheng J, Xiao X, Zhang Q et al (2015) Maternal and post-weaning high-fat, high-sucrose diet modulates glucose homeostasis and hypothalamic POMC promoter methylation in mouse offspring. Metab Brain Dis 30:1129–1137. doi: 10.1007/s11011-015-9678-9 PubMedCrossRefGoogle Scholar
  166. Zhong W, Zhang W, Li Q et al (2015) Pharmacological activation of aldehyde dehydrogenase 2 by Alda-1 reverses alcohol-induced hepatic steatosis and cell death in mice. J Hepatol 62:1375–1381. doi: 10.1016/j.jhep.2014.12.022 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  1. 1.Faculty of Medicine, Institute of BiochemistryUniversity of LeipzigLeipzigGermany
  2. 2.MCR Centre for Regenerative MedicineUniversity of EdinburghEH16 4UU EdinburghUK

Personalised recommendations